Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 697
of 35Next
1:

Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.

Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

Breast Cancer Res. 2008;10(4):R71. Epub 2008 Aug 21.

PMID: 18718015 [PubMed - in process]

2:

Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells.

Radestock Y, Hoang-Vu C, Hombach-Klonisch S.

Ann N Y Acad Sci. 2005 May;1041:462-9.

PMID: 15956747 [PubMed - indexed for MEDLINE]

3:

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.

PMID: 17786294 [PubMed - indexed for MEDLINE]

4:

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

PMID: 17980029 [PubMed - indexed for MEDLINE]

5:

Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer.

Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE, Jiang WG.

Breast Cancer Res. 2005;7(4):R402-10. Epub 2005 Apr 4.

PMID: 15987445 [PubMed - indexed for MEDLINE]

6:

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.

Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P.

Breast Cancer Res. 2005;7(4):R422-35. Epub 2005 Apr 4.

PMID: 15987447 [PubMed - indexed for MEDLINE]

7:

Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE.

Clin Cancer Res. 2005 Aug 15;11(16):6012-9.

PMID: 16115946 [PubMed - indexed for MEDLINE]

8:

The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer.

Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG.

Int J Oncol. 2008 Sep;33(3):585-93.

PMID: 18695890 [PubMed - indexed for MEDLINE]

9:

Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.

Li J, Sidell N.

Int J Cancer. 2005 Oct 20;117(1):14-20.

PMID: 15880583 [PubMed - indexed for MEDLINE]

10:

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. Epub 2008 Mar 7.

PMID: 18328103 [PubMed - indexed for MEDLINE]

11:

Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.

Kasper G, Reule M, Tschirschmann M, Dankert N, Stout-Weider K, Lauster R, Schrock E, Mennerich D, Duda GN, Lehmann KE.

BMC Cancer. 2007 Jan 17;7:12.

PMID: 17233884 [PubMed - indexed for MEDLINE]

12:

In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.

Haupt LM, Thompson EW, Trezise AE, Irving RE, Irving MG, Griffiths LR.

BMC Cancer. 2006 Jan 24;6:18.

PMID: 16430785 [PubMed - indexed for MEDLINE]

13:

[Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis]

Wang Z, Liu Q, Chen Q, Zhu R, Zhu HG.

Zhonghua Bing Li Xue Za Zhi. 2006 Jun;35(6):333-8. Chinese.

PMID: 16834906 [PubMed - indexed for MEDLINE]

14:

Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.

Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.

Toxicol Appl Pharmacol. 2008 Jan 15;226(2):178-91. Epub 2007 Sep 21.

PMID: 17961621 [PubMed - indexed for MEDLINE]

15:

Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1.

Lim KT, Cosgrave N, Hill AD, Young LS.

Breast Cancer Res. 2006;8(3):R33. Epub 2006 Jun 28.

PMID: 16805920 [PubMed - indexed for MEDLINE]

16:

[Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]

Fan J, Lu JS, Yin WJ, Lei W, Wu FY, Wu J, Hou YF, Li DQ, Di GH, Shen ZZ, Shao ZM.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):886-9. Chinese.

PMID: 17533736 [PubMed - indexed for MEDLINE]

17:

Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.

Lang JY, Chen H, Zhou J, Zhang YX, Zhang XW, Li MH, Lin LP, Zhang JS, Waalkes MP, Ding J.

Clin Cancer Res. 2005 May 1;11(9):3455-64.

PMID: 15867248 [PubMed - indexed for MEDLINE]

18:

Identification of the functional role of AF1Q in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2008 Sep;111(1):65-78. Epub 2007 Oct 11.

PMID: 17929166 [PubMed - indexed for MEDLINE]

19:

In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.

Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.

Med Oncol. 2005;22(2):129-38.

PMID: 15965275 [PubMed - indexed for MEDLINE]

20:

Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.

Hombach-Klonisch S, Bialek J, Trojanowicz B, Weber E, Holzhausen HJ, Silvertown JD, Summerlee AJ, Dralle H, Hoang-Vu C, Klonisch T.

Am J Pathol. 2006 Aug;169(2):617-32.

PMID: 16877360 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 697
of 35Next